Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

Adenocarcinoma of Head of Pancreas Clinical Trial

Official title:
Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

Status Not yet recruiting

Clinical Trial Summary

The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Adenocarcinoma
Adenocarcinoma of Head of Pancreas

Clinical Trial Details

NCT number	NCT01455610
Study type	Observational
Source	Shanghai Zhongshan Hospital
Contact	Mengsu Zeng, MD, PhD
Phone	+86-021-64041990-2130
Email	zengmengsu@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	October 2011
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02081131` - Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)	N/A
Completed	`NCT02487836` - Trial Evaluating the Efficacy of Laying a Biliary Stent for Producing a Heavy Chemotherapy in Unresectable Pancreatic Adenocarcinomas	Phase 2
Terminated	`NCT01677988` - Neoadjuvant Folfirinox Followed by Capecitabine and Limited Field Radiation for Localized Pancreatic Head Adenocarcinoma	Phase 2
Completed	`NCT02078232` - Comparison of Two Needles (19G Flex Versus 22G Standard) for Pancreatic Solid Tumors Diagnosis	N/A